CN Patent

CN1902200A — 用做蛋白激酶抑制剂的1h－咪唑并喹啉类衍生物

Assigned to Novartis AG · Expires 2007-01-24 · 19y expired

What this patent protects

本发明涉及用于治疗蛋白激酶依赖性疾病的式(I)咪唑并喹啉类化合物；包含咪唑并喹啉类化合物的药物制剂，尤其是用于治疗蛋白激酶依赖性疾病的所述药物制剂；新的咪唑并喹啉类化合物；以及制备新的咪唑并喹啉类化合物的方法。

USPTO Abstract

本发明涉及用于治疗蛋白激酶依赖性疾病的式(I)咪唑并喹啉类化合物；包含咪唑并喹啉类化合物的药物制剂，尤其是用于治疗蛋白激酶依赖性疾病的所述药物制剂；新的咪唑并喹啉类化合物；以及制备新的咪唑并喹啉类化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1902200A
Jurisdiction
CN
Classification
—
Expires
2007-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.